alcohol-related liver disease
Information
- Disease name
- alcohol-related liver disease
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT06183710 | Active, not recruiting | N/A | Contingency Management to Incentivise Treatment Adherence in Alcohol-related Liver Disease | January 1, 2023 | September 30, 2024 |
| NCT04287920 | Completed | Phase 2 | Acamprosate Safe to Use in Individuals With Liver Disease. | September 21, 2020 | January 5, 2022 |
| NCT01812226 | Completed | Alcohol Biomarkers in Post-Liver Transplant Patients | March 2013 | October 2015 | |
| NCT05623150 | Not yet recruiting | CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome | December 1, 2022 | March 2032 | |
| NCT06269510 | Not yet recruiting | N/A | Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients | April 2025 | July 2027 |
| NCT06305624 | Not yet recruiting | N/A | Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease | June 2024 | October 2027 |
| NCT06403332 | Recruiting | N/A | Study of the Drivers of Late Diagnosis of Alcohol Related Diseases, Alone or in Combination With Metabolic Dysfunconal Associated Fatty Liver Disease, Implementation and Evaluation of Itnerventions to Reduce Its Burden. | February 2, 2023 | December 6, 2024 |
| NCT06409130 | Recruiting | Phase 2 | Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease | May 20, 2024 | September 6, 2025 |
| NCT04876443 | Unknown status | Impact of COVID-19 Outbreak on the Alcohol Consumption in Patients With Alcohol-related Liver Disease (ICoLD) | October 8, 2020 | July 31, 2022 |